High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors

NCT06418789 · clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
25
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

N.N. Petrov National Medical Research Center of Oncology